Following the sale, Piskel directly owns 216,637 shares of Adaptive Biotechnologies. While analysts maintain a Buy consensus on the stock with a target price range of $18-$21, InvestingPro analysis ...
We recently published December Disappointments: 10 Big Names Troubled Early. Adaptive Biotechnologies Corp. (NASDAQ:ADPT) is one of the worst performers of last week. Adaptive Biotechnologies fell by ...
Adaptive Biotechnologies (NASDAQ:ADPT) Chief Financial Officer Kyle Piskel sold 162,820 shares of common stock on November 28, 2025, for approximately $3.17 million. The shares were sold in multiple ...
Adaptive Biotechnologies (NASDAQ:ADPT) Chief Financial Officer Kyle Piskel sold 238 shares of common stock on November 17, 2025, at a price of $14.05, for a total transaction value of $3343. The stock ...
Kids will learn how to make a simple pixel animation using the online Piskel app. Piskel can be used to create simple game sprites (i.e., 2D images overlaid onto a scene), GIF animations, and ...
Art focus: Video game design. Adviser nomination: “Aiden came in this year as a new game design student and has done a fantastic job all semester,” adviser Joe Wagner said. “He completed every major ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Seattle-based biotech is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results